Carregant...
CTLA-4 correlates with immune and clinical characteristics of glioma
BACKGROUND: CTLA-4 is a well-studied immune checkpoint protein that negatively regulates T cell-mediated immune responses. However, the expression of CTLA-4 in glioma and the effects of CTLA-4 on prognosis in patients with glioma have not yet been examined. METHODS: We investigated the protein level...
Guardat en:
| Publicat a: | Cancer Cell Int |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6945521/ https://ncbi.nlm.nih.gov/pubmed/31911758 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12935-019-1085-6 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|